Imagen de portada del programa BioTech Weekly

BioTech Weekly

Podcast de Ernst Oberortner

inglés

Tecnología y ciencia

Empieza 7 días de prueba

$99 / mes después de la prueba.Cancela cuando quieras.

  • 20 horas de audiolibros al mes
  • Podcasts solo en Podimo
  • Podcast gratuitos
Prueba gratis

Acerca de BioTech Weekly

Weekly podcast on the recent advancements in the Biotechnology field.

Todos los episodios

23 episodios

episode Special Issue: Agentic AI in Biotech artwork

Special Issue: Agentic AI in Biotech

🚀 𝗧𝗵𝗲 𝗘𝗿𝗮 𝗼𝗳 𝗔𝗴𝗲𝗻𝘁𝗶𝗰 𝗔𝗜 𝗶𝗻 𝗕𝗶𝗼𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗰𝘀 𝗶𝘀 𝗛𝗲𝗿𝗲. 𝗔𝗿𝗲 𝘆𝗼𝘂𝗿 𝘁𝗼𝗼𝗹𝘀 𝗿𝗲𝗮𝗱𝘆? 🧬 We are witnessing a massive shift in biotech. Large language models (LLMs) are moving beyond simple chatbots to become Agentic AI—semi-autonomous systems capable of perceiving, reasoning, and independently executing complex, multi-step workflows. In bioinformatics, these agents act as "junior scientists," capable of interpreting experimental designs, fetching data, and running analyses. 🤝 𝗪𝗵𝗮𝘁 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗰𝗼𝗺𝗺𝗼𝗻𝗮𝗹𝗶𝘁𝗶𝗲𝘀? Orchestration over Hallucination; Obsessive Reproducibility; Democratization via Natural Language; ✅ 𝗪𝗵𝗮𝘁 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗺𝘂𝘀𝘁-𝗵𝗮𝘃𝗲𝘀 𝗼𝗳 𝗮𝗴𝗲𝗻𝘁𝗶𝗰 𝗔𝗜 𝘀𝘆𝘀𝘁𝗲𝗺𝘀? "AI-Ready" Underlying Tools; Bounded Action Spaces; Human-in-the-Loop Governance; ⚠️ 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗺𝗶𝘀𝘀𝗶𝗻𝗴? (𝗧𝗵𝗲 𝗙𝗿𝗼𝗻𝘁𝗶𝗲𝗿) Standardized Value Metrics; Universal Metadata Harmonization; The Legacy Tool Migration; 𝗧𝗵𝗲 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆: Agentic AI is not replacing bioinformaticians; it is a force multiplier. It requires a "human-in-the-lead" to ensure clinical validity, govern the systems, and oversee the complex data orchestration. 🔗 𝗦𝗼𝘂𝗿𝗰𝗲𝘀 & 𝗟𝗶𝗻𝗸𝘀 𝘁𝗼 𝗘𝘅𝗽𝗹𝗼𝗿𝗲: * Agentic AI, explained (MIT Sloan): https://mitsloan.mit.edu/ideas-made-to-matter/agentic-ai-explained [https://mitsloan.mit.edu/ideas-made-to-matter/agentic-ai-explained] * Your Bioinformatics Tools Need to be AI-Ready (by Nils Homer, Ph.D. [https://www.linkedin.com/in/nilshomer?miniProfileUrn=urn%3Ali%3Afs_miniProfile%3AACoAAANTrrQBUF5S3t_qvR1kHChU1pX9-igNny0] ): https://fulcrumgenomics.com [https://fulcrumgenomics.com/] * https://pipette.bio [https://pipette.bio/] * https://github.com/Noricum-BioSoft/Helix.AI [https://github.com/Noricum-BioSoft/Helix.AI] * CellAtria: https://github.com/AstraZeneca/cellatria [https://github.com/AstraZeneca/cellatria] * OmicClaw & OmicVerse: http://omicverse.com/ [http://omicverse.com/] | https://github.com/Starlitnightly/omicverse [https://github.com/Starlitnightly/omicverse] * ClawBio: https://github.com/ClawBio/ClawBio [https://github.com/ClawBio/ClawBio] * BioPipelines: https://github.com/locbp-uzh/biopipelines [https://github.com/locbp-uzh/biopipelines] 𝘋𝘪𝘴𝘤𝘭𝘢𝘪𝘮𝘦𝘳: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out. 𝗟𝗲𝘁'𝘀 𝗱𝗶𝘀𝗰𝘂𝘀𝘀 𝗯𝗲𝗹𝗼𝘄! 👇

23 de mar de 2026 - 5 min
episode Biotech’s Year of 2025 in Review artwork

Biotech’s Year of 2025 in Review

Links (for anyone who wants to go deeper): 1. Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation https://bio.news/latest-news/breaking-barriers-to-a-cure-patient-perspectives-matter-in-type-1-diabetes-innovation/ [https://bio.news/latest-news/breaking-barriers-to-a-cure-patient-perspectives-matter-in-type-1-diabetes-innovation/] 2. Medicenna – Updates MDNA11 Clinical Trial Results at ESMO-IO Congress 2025 https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced-solid-tumors/ [https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced-solid-tumors/] 3. o2h Group Marks 20 Years with the 7th o2h Collaborative Innovation Conference https://o2h.com/press-release/o2h-group-marks-20-years-with-the-7th-o2h-collaborative-innovation-conference/ [https://o2h.com/press-release/o2h-group-marks-20-years-with-the-7th-o2h-collaborative-innovation-conference/] 4. Stunning images reveal how antibiotics shatter bacterial defenses https://www.sciencedaily.com/releases/2025/09/250929054907.htm [https://www.sciencedaily.com/releases/2025/09/250929054907.htm] 5. A new microscopy breakthrough is revealing the oceans’ invisible life https://www.sciencedaily.com/releases/2025/11/251101000359.htm [https://www.sciencedaily.com/releases/2025/11/251101000359.htm] 6. Don’t toss cannabis leaves. Scientists just found rare compounds inside https://www.sciencedaily.com/releases/2025/09/250910000258.htm [https://www.sciencedaily.com/releases/2025/09/250910000258.htm] 7. Patient advocates urge action on PPRV to help fight rare disease https://bio.news/federal-policy/patient-advocates-urge-action-on-pprv-to-help-fight-rare-disease/ [https://bio.news/federal-policy/patient-advocates-urge-action-on-pprv-to-help-fight-rare-disease/] 8. Morphocell Technologies – Completes US$50 Million Series A Financing https://www.biotech.ca/news/morphocell-technologies-inc-completes-us50-million-series-a-financing/ [https://www.biotech.ca/news/morphocell-technologies-inc-completes-us50-million-series-a-financing/] 9. Cloning isn’t just for celebrity pets like Tom Brady’s dog https://www.technologyreview.com/2025/11/07/1127692/cloning-celebrity-pets-tom-brady-dog-conservation/ [https://www.technologyreview.com/2025/11/07/1127692/cloning-celebrity-pets-tom-brady-dog-conservation/] 10. Scientists unlock nature’s secret to a cancer-fighting molecule https://www.sciencedaily.com/releases/2025/10/251009033206.htm [https://www.sciencedaily.com/releases/2025/10/251009033206.htm] 11. Mushrooms evolved psychedelics twice, baffling scientists https://www.sciencedaily.com/releases/2025/09/250924012226.htm [https://www.sciencedaily.com/releases/2025/09/250924012226.htm] Curious: which one would you most want a 2-minute breakdown on — patient-led innovation, microscopy, or nature’s drug-discovery hacks? Disclaimer: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out.

8 de ene de 2026 - 12 min
episode BioTech Weekly - Dec 01-14, 2025 artwork

BioTech Weekly - Dec 01-14, 2025

🔬 This Week’s Top Biotech News 1️⃣ Medicenna Therapeutics Corp – MDNA11 clinical trial update at ESMO-IO 2025 👉 https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced-solid-tumors/ [https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced-solid-tumors/] 2️⃣ Charlotte emerging as a global leader in healthcare innovation and medtech 👉 https://bio.news/state-policy/charlotte-emerging-as-a-global-leader-in-health-care-innovation-and-med-tech/ [https://bio.news/state-policy/charlotte-emerging-as-a-global-leader-in-health-care-innovation-and-med-tech/] 3️⃣ Ventus Therapeutics – First patient dosed in Phase 2 trial of VENT-03 for lupus 👉 https://www.biotech.ca/news/ventus-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-vent-03-a-novel-small-molecule-cgas-inhibitor-in-patients-with-lupus/ [https://www.biotech.ca/news/ventus-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-vent-03-a-novel-small-molecule-cgas-inhibitor-in-patients-with-lupus/] 4️⃣ Morphocell Technologies Inc – Completes US$50M Series A 👉 https://www.biotech.ca/news/morphocell-technologies-inc-completes-us50-million-series-a-financing/ [https://www.biotech.ca/news/morphocell-technologies-inc-completes-us50-million-series-a-financing/] 5️⃣ U.S. House passes BIO-backed legislation to increase access to capital 👉 https://bio.news/federal-policy/house-passes-bio-backed-legislation-to-increase-access-to-capital/ [https://bio.news/federal-policy/house-passes-bio-backed-legislation-to-increase-access-to-capital/] 6️⃣ SWCC – Global Biotech Week: science, innovation, community 👉 https://www.biotech.ca/news/swcc-science-writers-global-biotech-week-uniting-science-innovation-and-community/ [https://www.biotech.ca/news/swcc-science-writers-global-biotech-week-uniting-science-innovation-and-community/] 7️⃣ Neurenati Therapeutics Inc – New board and advisory appointments 👉 https://www.biotech.ca/news/neurenati-therapeutics-inc-welcomes-dr-daniel-guay-to-its-board-of-directors-and-dr-carlo-di-lorenzo-to-its-scientific-and-clinical-advisory-board/ [https://www.biotech.ca/news/neurenati-therapeutics-inc-welcomes-dr-daniel-guay-to-its-board-of-directors-and-dr-carlo-di-lorenzo-to-its-scientific-and-clinical-advisory-board/] 8️⃣ BIO-CSBA report on how states attract biotech 👉 https://bio.news/state-policy/bio-csba-report-explains-why-and-how-states-seek-to-attract-biotech/ [https://bio.news/state-policy/bio-csba-report-explains-why-and-how-states-seek-to-attract-biotech/] 9️⃣ 🎧 Podcast – Cracking Cancer’s Code 👉 https://www.labiotech.eu/podcast/cracking-cancers-code-transforming-research-with-novel-cancer-models/ [https://www.labiotech.eu/podcast/cracking-cancers-code-transforming-research-with-novel-cancer-models/] 🔟 Synthetic biology – Manual released for building synthetic genomes 👉 https://phys.org/news/2025-12-genome-scientists-manual-synthetic-life.html [https://phys.org/news/2025-12-genome-scientists-manual-synthetic-life.html] ⚠️ Disclaimer: Some podcast content uses LLMs; please independently verify details. #Biotech #Biotechnology #Science #Innovation #Healthcare #Research

18 de dic de 2025 - 16 min
episode BioTech Weekly - Nov 17-30, 2025 artwork

BioTech Weekly - Nov 17-30, 2025

🔬 This Week's Top Biotech News 1. Zymeworks – Positive HERIZON-GEA-01 Phase 3 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive GEA https://www.biotech.ca/news/zymeworks-announces-positive-herizon-gea-01-phase-3-results-supporting-ziihera/ [https://www.biotech.ca/news/zymeworks-announces-positive-herizon-gea-01-phase-3-results-supporting-ziihera/] 2. Actuate Therapeutics – Elraglusib shows promise vs pancreatic cancer https://www.genengnews.com/topics/cancer/backbone-potential-actuates-elraglusib-shows-promise-vs-pancreatic-cancer/ [https://www.genengnews.com/topics/cancer/backbone-potential-actuates-elraglusib-shows-promise-vs-pancreatic-cancer/] 3. Kapoose Creek Bio – Awards enable two new drug discovery studies https://www.biotech.ca/news/kapoose-creek-bio-recent-awards-power-two-new-studies-into-drug-discovery-and-development/ [https://www.biotech.ca/news/kapoose-creek-bio-recent-awards-power-two-new-studies-into-drug-discovery-and-development/] 4. BIO on the American Road – Indiana expands as a biotech production hub https://bio.news/bio-convention/bio-on-the-american-road-indiana-a-production-powerhouse-is-still-expanding/ [https://bio.news/bio-convention/bio-on-the-american-road-indiana-a-production-powerhouse-is-still-expanding/] 5. MIT Tech Review – What we still don’t know about weight-loss drugs https://www.technologyreview.com/2025/11/28/1128511/what-we-still-dont-know-about-weight-loss-drugs/ [https://www.technologyreview.com/2025/11/28/1128511/what-we-still-dont-know-about-weight-loss-drugs/] 6. BIO IP Conference – Research underscores need for strong biotech patents https://bio.news/bio-convention/ahead-of-bio-ip-conference-research-highlights-why-biotech-needs-strong-patents/ [https://bio.news/bio-convention/ahead-of-bio-ip-conference-research-highlights-why-biotech-needs-strong-patents/] 7. GEN – Cyanobacterial pigments boost bioprocessing for biomedicine https://www.genengnews.com/topics/bioprocessing/cyanobacterial-pigments-advance-biomedicine-through-smarter-bioprocessing/ [https://www.genengnews.com/topics/bioprocessing/cyanobacterial-pigments-advance-biomedicine-through-smarter-bioprocessing/] 8. BIO Coffee Chat – Helping patients navigate Part D open enrollment https://bio.news/federal-policy/bio-coffee-chat-guiding-patients-through-part-d-open-enrollment/ [https://bio.news/federal-policy/bio-coffee-chat-guiding-patients-through-part-d-open-enrollment/] 9. Industry–Academia Collaboration – Improving cell & gene therapy manufacturing https://www.genengnews.com/topics/bioprocessing/industry-academia-collaboration-formed-to-improve-cell-and-gene-therapy-manufacturing/ [https://www.genengnews.com/topics/bioprocessing/industry-academia-collaboration-formed-to-improve-cell-and-gene-therapy-manufacturing/] 10. CSL Seqirus – New evidence supports broader adoption of enhanced flu vaccines https://www.biotech.ca/news/csl-seqirus-enhanced-influenza-vaccines/ [https://www.biotech.ca/news/csl-seqirus-enhanced-influenza-vaccines/] 11. New Gene Therapy Standards – Updated guidance to support manufacturers https://www.genengnews.com/topics/bioprocessing/new-standards-aim-to-support-gene-therapy-manufacturers/ [https://www.genengnews.com/topics/bioprocessing/new-standards-aim-to-support-gene-therapy-manufacturers/] Disclaimer: The content was generated with LLM assistance. While care has been taken to ensure accuracy, LLMs may produce incorrect or incomplete information. Please verify any critical details, share feedback, and reach out with questions. #Biotech #Biotechnology #Science #Innovation #Healthcare #Research

2 de dic de 2025 - 18 min
episode BioTech Weekly - Nov 3-16, 2025 artwork

BioTech Weekly - Nov 3-16, 2025

🔬 This Week’s Top Biotech News Here are the key developments in biotechnology this week 👇 1. Merck to Acquire Cidara for $9.2B, Bolstering Antiviral Pipeline [https://www.genengnews.com/topics/infectious-diseases/merck-to-acquire-cidara-for-9-2b-bolstering-antiviral-pipeline/] 2. BIO CEO John Crowley Tells Senate How to Support Biotech [https://bio.news/federal-policy/bio-ceo-john-crowley-tells-senate-how-to-support-biotech/] 3. A Future Beyond Animal Testing: Why ORIVA Matters and How Computational Models Bridge the Gap [https://www.genengnews.com/topics/translational-medicine/a-future-beyond-animal-testing-why-oriva-matters-and-how-computational-models-bridge-the-gap/] 4. Cervical Cancer May Be Treatable with Intranasal Nanogel Vaccine [https://www.genengnews.com/topics/cancer/cervical-cancer-may-be-treatable-with-intranasal-nanogel-vaccine/] 5. AI Model Could Boost Liver Transplant Efficiency by Predicting Donor Death Timing [https://www.genengnews.com/topics/translational-medicine/ai-model-could-boost-liver-transplant-efficiency-by-predicting-donor-death-timing/] 6. Genetic Agency on Display at GATC 2025 [https://www.genengnews.com/topics/genome-editing/genetic-agency-on-display-at-gatc-2025/] 7. These Technologies Could Help Put a Stop to Animal Testing [https://www.technologyreview.com/2025/11/14/1127949/technologies-could-stop-animal-testing/] 8. New Cancer Cell Discovery Sheds Light on Childhood Blood Cancer [https://www.labiotech.eu/trends-news/ztbb16-discovery-childhood-leukemia/] 9. Federal Budget Delivers Breakthrough Wins for Canada’s Life Sciences Sector [https://www.biotech.ca/news/federal-budget-delivers-breakthrough-wins-for-canadas-biotechnology-sector/] 10. Optical Genome Mapping Links Chromosomal Changes to Recurrent Pregnancy Loss [https://www.genengnews.com/topics/translational-medicine/optical-genome-mapping-links-chromosomal-changes-to-recurrent-pregnancy-loss/] 11. Cloning Isn’t Just for Celebrity Pets Like Tom Brady’s Dog [https://www.technologyreview.com/2025/11/07/1127692/cloning-celebrity-pets-tom-brady-dog-conservation/] From AI-driven organ transplants to new cancer discoveries and synthetic biology ethics, the biotech frontier keeps expanding. Disclaimer: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out. #Biotech #Biotechnology #Science #Innovation #Healthcare #Research #LifeSciences

17 de nov de 2025 - 15 min
Muy buenos Podcasts , entretenido y con historias educativas y divertidas depende de lo que cada uno busque. Yo lo suelo usar en el trabajo ya que estoy muchas horas y necesito cancelar el ruido de al rededor , Auriculares y a disfrutar ..!!
Muy buenos Podcasts , entretenido y con historias educativas y divertidas depende de lo que cada uno busque. Yo lo suelo usar en el trabajo ya que estoy muchas horas y necesito cancelar el ruido de al rededor , Auriculares y a disfrutar ..!!
Fantástica aplicación. Yo solo uso los podcast. Por un precio módico los tienes variados y cada vez más.
Me encanta la app, concentra los mejores podcast y bueno ya era ora de pagarles a todos estos creadores de contenido

Elige tu suscripción

Más populares

Premium

20 horas de audiolibros

  • Podcasts solo en Podimo

  • Disfruta los shows de Podimo sin anuncios

  • Cancela cuando quieras

Empieza 7 días de prueba
Después $99 / mes

Prueba gratis

Sólo en Podimo

Audiolibros populares

Prueba gratis

Empieza 7 días de prueba. $99 / mes después de la prueba. Cancela cuando quieras.